Sox2 encoded one of the reprogramming factors important for stem cell maintenance and cell fate determination (Takahashi et al., 2007; Feng et al., 2009) and was suggested as a biomarker to distinguish between NP and AF cells in vivo (Li et al., 2019b). The gene discussed is SOX2; the disease is atrial fibrillation.